Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

Letter: Medicare’s decision wrong on Alzheimer’s drug – Times Union,

In July 2021, the U.S. Food and Drug Administration approved aducanumab … will not pay for aducanumab except in the setting of clinical trials., In July 2021, the U.S. Food and Drug Administration approved aducanumab … will not pay for aducanumab except in the setting of clinical trials., Read More

Scroll to Top